← Back to Treatments
🏅 FDA Orphan Designation

Betaseron

Interferon beta-1b

Manufacturer: Chiron Corp. & Berlex Laboratories

Indicated for:
NON RARE IN EUROPE: Multiple sclerosis

FDA-Approved Indications (1)

indicated for the treatment of relapsing forms of multiple sclerosis, to include active secondary progressive disease

Population: adults

Indications & Usage

1 INDICATIONS AND USAGE BETASERON is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. BETASERON is an interferon beta indicated for the treatment of relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. ( 1 )

💙 Support Programs

View all →
Betaseron
Bayer
Copay card ↗Apply ↗

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.